Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study
Clinical trial NCT04793568 · UNKNOWN
Trial details
- NCT number
- NCT04793568
- Sponsor
- Nantes University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2021-11-07
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.